Cancer biotherapy & radiopharmaceuticals

Keyphrases

Publications

2024

Liwen Feng, Yuting Chen, Xiangping Mei, Lei Wang, Wenjing Zhao, Jiannan Yao
Prognostic Signature in Osteosarcoma Based on Amino Acid Metabolism-Associated Genes. Cancer biotherapy & radiopharmaceuticals (2024)
Ruoyang Li, Xuewei Zhao, Yunfei Huang, Chunxiao Li, Lei Liu, Meiqi Wang, Jiaxing Wang, Zhenchuan Song
The Survival Benefit of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in the Management of Breast Cancer. Cancer biotherapy & radiopharmaceuticals (2024)

volume 39, number 1, 2024

Tom Bäck, Per Albertsson, Emma Aneheim, Ragnar Hultborn, Lars Jacobsson, Sture Lindegren, Stig Palm
A Novel Method for Real-Time Quantification of Radioligand Binding to Living Tumor Cells In Vitro . Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)
Tom Bäck, Per Albertsson, Emma Aneheim, Ragnar Hultborn, Lars Jacobsson, Sture Lindegren, Stig Palm
A Novel Method for Real-Time Quantification of Radioligand Binding to Living Tumor Cells In Vitro . Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)
Tom Bäck, Per Albertsson, Emma Aneheim, Ragnar Hultborn, Lars Jacobsson, Sture Lindegren, Stig Palm
A Novel Method for Real-Time Quantification of Radioligand Binding to Living Tumor Cells In Vitro . Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)
Sudipta Chakraborty, Sucheta Chatterjee, Rubel Chakravarty, Haldhar D Sarma, Raviteja Nanabala, Dibakar Goswami, Ajith Joy, Maroor Raghavan Ambikalamajan Pillai
Synthesis, Quality Control, and Bench-to-Bed Translation of a New [ 68 Ga]Ga-Labeled NOTA-Conjugated Bisphosphonate for Imaging Skeletal Metastases by Positron Emission Tomography. Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)
Rohit Sharma, Archana Mukherjee, Anuj Kumar, Haladhar Dev Sarma
Evaluation of 177 Lu-Labeled Pertuzumab F(ab') 2 Fragments for HER2-Positive Cancer Targeting: A Comparative In Vitro and In Vivo Study. Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)
Sudipta Chakraborty, Sucheta Chatterjee, Rubel Chakravarty, Haldhar D Sarma, Raviteja Nanabala, Dibakar Goswami, Ajith Joy, Maroor Raghavan Ambikalamajan Pillai
Synthesis, Quality Control, and Bench-to-Bed Translation of a New [ 68 Ga]Ga-Labeled NOTA-Conjugated Bisphosphonate for Imaging Skeletal Metastases by Positron Emission Tomography. Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)
Shiqi Yan, Yilin Guo, Lizhong Lin, Wenling Zhang
Breaks for Precision Medicine in Cancer: Development and Prospects of Spatiotemporal Transcriptomics. Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)
Rohit Sharma, Archana Mukherjee, Anuj Kumar, Haladhar Dev Sarma
Evaluation of 177 Lu-Labeled Pertuzumab F(ab') 2 Fragments for HER2-Positive Cancer Targeting: A Comparative In Vitro and In Vivo Study. Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)
K V Vimalnath, Ardhi Rajeswari, Anupam Dixit, Rubel Chakravarty, Haldhar D Sarma, Suyash Kulkarni, Ashish Jha, Ameya Puranik, Venkatesh Rangarajan, Madhumita Goswami, Sudipta Chakraborty
[ 90 Y]Yttria Alumino Silicate Glass Microspheres: A Biosimilar Formulation to "TheraSphere" for Cost-Effective Treatment of Liver Cancer. Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)
Tom Bäck, Per Albertsson, Emma Aneheim, Ragnar Hultborn, Lars Jacobsson, Sture Lindegren, Stig Palm
A Novel Method for Real-Time Quantification of Radioligand Binding to Living Tumor Cells In Vitro . Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)
Shiqi Yan, Yilin Guo, Lizhong Lin, Wenling Zhang
Breaks for Precision Medicine in Cancer: Development and Prospects of Spatiotemporal Transcriptomics. Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)
K V Vimalnath, Ardhi Rajeswari, Anupam Dixit, Rubel Chakravarty, Haldhar D Sarma, Suyash Kulkarni, Ashish Jha, Ameya Puranik, Venkatesh Rangarajan, Madhumita Goswami, Sudipta Chakraborty
[ 90 Y]Yttria Alumino Silicate Glass Microspheres: A Biosimilar Formulation to "TheraSphere" for Cost-Effective Treatment of Liver Cancer. Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)
Sudipta Chakraborty, Sucheta Chatterjee, Rubel Chakravarty, Haldhar D Sarma, Raviteja Nanabala, Dibakar Goswami, Ajith Joy, Maroor Raghavan Ambikalamajan Pillai
Synthesis, Quality Control, and Bench-to-Bed Translation of a New [ 68 Ga]Ga-Labeled NOTA-Conjugated Bisphosphonate for Imaging Skeletal Metastases by Positron Emission Tomography. Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)
Shiqi Yan, Yilin Guo, Lizhong Lin, Wenling Zhang
Breaks for Precision Medicine in Cancer: Development and Prospects of Spatiotemporal Transcriptomics. Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)
K V Vimalnath, Ardhi Rajeswari, Anupam Dixit, Rubel Chakravarty, Haldhar D Sarma, Suyash Kulkarni, Ashish Jha, Ameya Puranik, Venkatesh Rangarajan, Madhumita Goswami, Sudipta Chakraborty
[ 90 Y]Yttria Alumino Silicate Glass Microspheres: A Biosimilar Formulation to "TheraSphere" for Cost-Effective Treatment of Liver Cancer. Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)
Tom Bäck, Per Albertsson, Emma Aneheim, Ragnar Hultborn, Lars Jacobsson, Sture Lindegren, Stig Palm
A Novel Method for Real-Time Quantification of Radioligand Binding to Living Tumor Cells In Vitro . Cancer biotherapy & radiopharmaceuticals 39 (1) (2024)

volume 39, number 3, 2024

Yinbing Wu, Huafei Tang, Quanxing Liao, Yinuo Tu, Shuxian Fang, Jinfu He, Shuzhong Cui
Curcumol Inhibits the Progression of Hepatocellular Carcinoma by Regulating the Expression of hsa_circ_0028861. Cancer biotherapy & radiopharmaceuticals 39 (3) (2024)
Xiaojing Jiang, Tianyue Li, Jianfang Wang, Zhaoqi Zhang, Xiaolin Chen, Jingmian Zhang, Xinming Zhao
Noninvasive Assessment of HER2 Expression Status in Gastric Cancer Using 18 F-FDG Positron Emission Tomography/Computed Tomography-Based Radiomics: A Pilot Study. Cancer biotherapy & radiopharmaceuticals 39 (3) (2024)
Yinbing Wu, Huafei Tang, Quanxing Liao, Yinuo Tu, Shuxian Fang, Jinfu He, Shuzhong Cui
Curcumol Inhibits the Progression of Hepatocellular Carcinoma by Regulating the Expression of hsa_circ_0028861. Cancer biotherapy & radiopharmaceuticals 39 (3) (2024)
Xiaojing Jiang, Tianyue Li, Jianfang Wang, Zhaoqi Zhang, Xiaolin Chen, Jingmian Zhang, Xinming Zhao
Noninvasive Assessment of HER2 Expression Status in Gastric Cancer Using 18 F-FDG Positron Emission Tomography/Computed Tomography-Based Radiomics: A Pilot Study. Cancer biotherapy & radiopharmaceuticals 39 (3) (2024)
Xiaojing Jiang, Tianyue Li, Jianfang Wang, Zhaoqi Zhang, Xiaolin Chen, Jingmian Zhang, Xinming Zhao
Noninvasive Assessment of HER2 Expression Status in Gastric Cancer Using 18 F-FDG Positron Emission Tomography/Computed Tomography-Based Radiomics: A Pilot Study. Cancer biotherapy & radiopharmaceuticals 39 (3) (2024)
Aarti Aggarwal, Gurjeet Kaur, Ravjit Singh Jassal, Bikash Medhi, Bhagwant Rai Mittal, Jaya Shukla
Unraveling Interaction of Rhenium-188 Microspheres with Primary Hepatic Cancer Cell: A Breakthrough Study. Cancer biotherapy & radiopharmaceuticals 39 (3) (2024)
Aarti Aggarwal, Gurjeet Kaur, Ravjit Singh Jassal, Bikash Medhi, Bhagwant Rai Mittal, Jaya Shukla
Unraveling Interaction of Rhenium-188 Microspheres with Primary Hepatic Cancer Cell: A Breakthrough Study. Cancer biotherapy & radiopharmaceuticals 39 (3) (2024)
Aarti Aggarwal, Gurjeet Kaur, Ravjit Singh Jassal, Bikash Medhi, Bhagwant Rai Mittal, Jaya Shukla
Unraveling Interaction of Rhenium-188 Microspheres with Primary Hepatic Cancer Cell: A Breakthrough Study. Cancer biotherapy & radiopharmaceuticals 39 (3) (2024)

volume 39, number 4, 2024

Jing Ai, Shuang Zhang, Yimeng Qian, Lin Kang, Litao Zhang, Jing Zhao
Radiotherapy and Anrotinib in Malignant Glomus Tumor of the Bladder: A Case Report and Literature Review. Cancer biotherapy & radiopharmaceuticals 39 (4) (2024)
Jing Ai, Shuang Zhang, Yimeng Qian, Lin Kang, Litao Zhang, Jing Zhao
Radiotherapy and Anrotinib in Malignant Glomus Tumor of the Bladder: A Case Report and Literature Review. Cancer biotherapy & radiopharmaceuticals 39 (4) (2024)

volume 39, number 5, 2024

Julien Dubois, Guillaume Tosato, Philippe Garrigue, David Taieb, Benjamin Guillet, Vincent Nail
Short-Term Biological Toxicity Prediction of [ 177 Lu]Lutetium-Oxodotreotide: An Original Retrospective Analysis. Cancer biotherapy & radiopharmaceuticals 39 (5) (2024)
Caner Civan, Zeynep Gözde Özkan, Berker Ozkan, Emine Göknur Işik, Eren Erdoğdu, Duygu Has Şimşek, Salih Duman, Yasemin Sanli, Murat Kara, Serkan Kuyumcu, Alper Toker
The Role of [ 18 F]FDG PET/CT in the Characterization of Thymic Epithelial Tumors at Initial Stage. Cancer biotherapy & radiopharmaceuticals 39 (5) (2024)
Julien Dubois, Guillaume Tosato, Philippe Garrigue, David Taieb, Benjamin Guillet, Vincent Nail
Short-Term Biological Toxicity Prediction of [ 177 Lu]Lutetium-Oxodotreotide: An Original Retrospective Analysis. Cancer biotherapy & radiopharmaceuticals 39 (5) (2024)
Julien Dubois, Guillaume Tosato, Philippe Garrigue, David Taieb, Benjamin Guillet, Vincent Nail
Short-Term Biological Toxicity Prediction of [ 177 Lu]Lutetium-Oxodotreotide: An Original Retrospective Analysis. Cancer biotherapy & radiopharmaceuticals 39 (5) (2024)
Luca Filippi
Re: "Evaluating the Diagnostic Efficacy of 99m Tc-Methionine Single-Photon Emission Computed Tomography-Computed Tomography: A Head-to-Head Comparison with 11 C-Methionine Positron Emission Tomography-Magnetic Resonance Imaging in Glioma Patients" by Kumar et al. Cancer biotherapy & radiopharmaceuticals 39 (5) (2024)
Marcos Tassano, Ximena Camacho, Teresa Freire, Carolina Perroni, Valeria da Costa, Mirel Cabrera, Maria Fernanda García, Marcelo Fernandez, Juan Pablo Gambini, Pablo Cabral, Eduardo Osinaga
Enhanced Tumor Targeting of Radiolabeled Mouse/Human Chimeric Anti-Tn Antibody in Losartan-Treated Mice Bearing Tn-Expressing Lung Tumors. Cancer biotherapy & radiopharmaceuticals 39 (5) (2024)
Julien Dubois, Guillaume Tosato, Philippe Garrigue, David Taieb, Benjamin Guillet, Vincent Nail
Short-Term Biological Toxicity Prediction of [ 177 Lu]Lutetium-Oxodotreotide: An Original Retrospective Analysis. Cancer biotherapy & radiopharmaceuticals 39 (5) (2024)
Marcos Tassano, Ximena Camacho, Teresa Freire, Carolina Perroni, Valeria da Costa, Mirel Cabrera, Maria Fernanda García, Marcelo Fernandez, Juan Pablo Gambini, Pablo Cabral, Eduardo Osinaga
Enhanced Tumor Targeting of Radiolabeled Mouse/Human Chimeric Anti-Tn Antibody in Losartan-Treated Mice Bearing Tn-Expressing Lung Tumors. Cancer biotherapy & radiopharmaceuticals 39 (5) (2024)
Pardeep Kumar Kumar, Aishwarya Kumar, Chandana Nagaraj, Nishanth Sadashiva, Jitender Saini, Sandhya Mangalore, Archith Rajan, Keerti Sitani, Manish Beniwal, Vani Santosh, Harish Basavaraja, Puja Panwar Hazari, Anil Kumar Mishra
Evaluating the Diagnostic Efficacy of 99m Tc-Methionine Single-Photon Emission Computed Tomography-Computed Tomography: A Head-to-Head Comparison with 11 C-Methionine Positron Emission Tomography-Magnetic Resonance Imaging in Glioma Patients. Cancer biotherapy & radiopharmaceuticals 39 (5) (2024)
Chuang-Hsin Chiu, David J Yang, Yi-Chen Liou, Wei-Chung Chang, Tsung-Hsun Yu, Min-Ching Chung, Yen-Chun Lee, Ing-Jou Chen, Pao-Yeh Wang, Ching-Po Lin, Hey-Jen Tsay, Skye Hsin-Hsien Yeh
Assessment of DNA/RNA Deregulation in Cancer Using 99m Tc-Labeled Thiopurine. Cancer biotherapy & radiopharmaceuticals 39 (5) (2024)
J Harvey Turner
Theranostic Innovation by Humane N-of-One Cancer Care in Real-World Patients. Cancer biotherapy & radiopharmaceuticals 39 (5) (2024)
J Harvey Turner
Theranostic Innovation by Humane N-of-One Cancer Care in Real-World Patients. Cancer biotherapy & radiopharmaceuticals 39 (5) (2024)
Bilal Kovan, Dilara Denizmen, Caner Civan, Serkan Kuyumcu, Emine Göknur Işik, Duygu Has Şimşek, Zeynep Gözde Özkan, Arzu Poyanli, Bayram Demir, Yasemin Sanli
Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on 90 Y Selective Internal Radiation Therapy Planning. Cancer biotherapy & radiopharmaceuticals 39 (5) (2024)

volume 39, number 6, 2024

Xun Tang, Jun Wu, Yan Chen, Daojuan Wang, Tingyu Wang, Yajing Weng, Zhengquan Zhu, Rui Peng, Yong Wang, Feng Yan
Evaluation of 5'-tRF-His-GTG As a Molecular Biomarker in Breast Cancer Diagnoses and Prognosis. Cancer biotherapy & radiopharmaceuticals 39 (6) (2024)
Leilei Liu, Jingyun Zhao, Hui Guo, Jingde Jia, Li Shi, Jing Ma, Zhengmao Zhang
Participation of Long Noncoding RNA FOXP4-AS1 in the Development and Progression of Endometrioid Carcinoma with Epigenetically Silencing DUSP5 . Cancer biotherapy & radiopharmaceuticals 39 (6) (2024)
Luca Filippi, Martin W Brechbiel
Molecular Breast Imaging of HER2-Positive Breast Cancer in the Era of PHERGain Trial: The past, the Present, and the Prospects. Cancer biotherapy & radiopharmaceuticals 39 (6) (2024)
Yibo Chen, Tianyi Zhang, Rui Zhang, Xuchen Cao
Pyrotinib and Trastuzumab Plus Chemotherapy Serve as an Acceptable Neoadjuvant Regimen Exhibiting Good Efficacy and Tolerance in HER2-Positive Breast Cancer Patients. Cancer biotherapy & radiopharmaceuticals 39 (6) (2024)
Xiaolu Hong, Xiaoping Pan
Exosome-Derived MicroRNA-221-3p Desensitizes Breast Cancer Cells to Adriamycin by Regulating PIK3r1 -Mediated Glycose Metabolism. Cancer biotherapy & radiopharmaceuticals 39 (6) (2024)
Xiaolu Hong, Xiaoping Pan
Exosome-Derived MicroRNA-221-3p Desensitizes Breast Cancer Cells to Adriamycin by Regulating PIK3r1 -Mediated Glycose Metabolism. Cancer biotherapy & radiopharmaceuticals 39 (6) (2024)
Leilei Liu, Jingyun Zhao, Hui Guo, Jingde Jia, Li Shi, Jing Ma, Zhengmao Zhang
Participation of Long Noncoding RNA FOXP4-AS1 in the Development and Progression of Endometrioid Carcinoma with Epigenetically Silencing DUSP5 . Cancer biotherapy & radiopharmaceuticals 39 (6) (2024)
Yibo Chen, Tianyi Zhang, Rui Zhang, Xuchen Cao
Pyrotinib and Trastuzumab Plus Chemotherapy Serve as an Acceptable Neoadjuvant Regimen Exhibiting Good Efficacy and Tolerance in HER2-Positive Breast Cancer Patients. Cancer biotherapy & radiopharmaceuticals 39 (6) (2024)

volume 39, number 7, 2024

Alessandra Alessi
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Cancer Biotherapy and Radiopharmaceuticals . Cancer biotherapy & radiopharmaceuticals 39 (7) (2024)